Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes
Article
[키워드] acute respiratory syndrome
analyzed
antibodies
antiviral therapy
approved
biosafety
Biosafety Level 3
can be used
caused
classical
coefficient
convalescent COVID-19 patient
convalescent COVID-19 patients
coronavirus
correlated
detect
determine
displaying
genus Betacoronavirus
homologous
Immune status
morbidities
MOST
neutralization titer
neutralized
Neutralizing antibodies
neutralizing antibody
Neutralizing antibody titer
pandemic virus
passive immunization
patient cohort
Pearson correlation
performed
pseudotype virus
pseudovirus
quantification
Rapid
robust
SARS-CoV-1
SARS-CoV-2
SARS-CoV-2 neutralization
SARS-CoV-2-neutralizing antibodies
SARS-CoV-2-neutralizing antibody
sera
serum
Spike protein
the SARS-CoV-2
therapeutic
vaccinated individuals
Vaccine
Vaccines
vesicular
vesicular stomatitis virus
VSV
[DOI] 10.3390/vaccines8030386 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/vaccines8030386 PMC 바로가기 [Article Type] Article